Inventor · disambiguated record
Paul Gibbons
Also filed as: GIBBONS PAUL · GIBBONS PAUL A · GIBBONS PAUL ANTHONY
17 granted patents·21 pending applications·86 citations·filing 2005–2024
90Inventor score
Top patents by PatentIndex Score
38 records- 0191US11858915B2Polo like kinase 4 inhibitorsORIC PHARMACEUTICALS INC·Filed 2023·Granted Jan 2, 2024·3 cites·21 claims
- 0289US8461328B2Tricyclic heterocyclic compounds, compositions and methods of use thereofBABU SRINIVASAN·Filed 2011·Granted Jun 11, 2013·36 cites·18 claims
- 0387US8999998B2Pyrazolopyrimidine JAK inhibitor compounds and methodsGIBBONS PAUL·Filed 2010·Granted Apr 7, 2015·7 cites·1 claims
- 0487US8637526B2Pyrazolopyrimidine JAK inhibitor compounds and methodsBLANEY JEFFREY·Filed 2011·Granted Jan 28, 2014·17 cites·18 claims
- 0585US2024150364A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2023·Application pending·0 cites
- 0680US10010549B2Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2015·Granted Jul 3, 2018·2 cites·10 claims
- 0777US2022389020A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2022·Application pending·0 cites
- 0874US11155557B2Pyrazolopyrimidine compounds and methods of use thereofGENENTECH INC·Filed 2019·Granted Oct 26, 2021·1 cites·19 claims
- 0974US7814916B2Implantable marker, instruments and methodsREVIE IAN·Filed 2005·Granted Oct 19, 2010·20 cites·35 claims
- 1073US11129832B2Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2019·Granted Sep 28, 2021·0 cites·27 claims
- 1172US2023206644A1Pyrazolopyrimidine compounds as jak inhibitorsGENENTECH INC·Filed 2023·Application pending·0 cites
- 1272US2022204517A1Inhaled powder formulationsGENENTECH INC·Filed 2022·Application pending·0 cites
- 1371US2020002345A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2019·Application pending·0 cites
- 1470US12312339B2Polo like kinase 4 inhibitorsORIC PHARMACEUTICALS INC·Filed 2023·Granted May 27, 2025·0 cites·22 claims
- 1568US11795170B2Therapeutic compounds, compositions and methods of use thereofGENENTECH INC·Filed 2020·Granted Oct 24, 2023·0 cites·2 claims
- 1667US2024400579A1Spirocyclic modulators of cholesterol biosynthesis and their use for promoting remyelinationGENENTECH INC·Filed 2024·Application pending·0 cites
- 1765US2024270722A1Polo like kinase 4 inhibitorsORIC PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1864US11731943B2Therapeutic compounds, compositions and methods of use thereofGENENTECH INC·Filed 2021·Granted Aug 22, 2023·0 cites·8 claims
- 1964US2018133219A1Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 2064US2017283424A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2017·Application pending·0 cites
- 2161US2020339604A1Pyrazolopyrimidine compounds as jak inhibitorsGENENTECH INC·Filed 2020·Application pending·0 cites
- 2261US2020165260A1Inhaled powder formulationsGENENTECH INC·Filed 2020·Application pending·0 cites
- 2360US2023159555A1Sulfonimidamide compounds as nlrp3 modulatorsGENENTECH INC·Filed 2022·Application pending·0 cites
- 2458US2025034159A1Inhibitors of epidermal growth factor receptorORIC PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2557US2022249487A1Quinazolinyl compounds and methods of useGENENTECH INC·Filed 2021·Application pending·0 cites
- 2657US2014107099A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2013·Application pending·0 cites
- 2756US2018265515A1Therapeutic compounds and compositions, and methods of use thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 2855US12358951B2Cyclic peptide antibioticsGENENTECH INC·Filed 2021·Granted Jul 15, 2025·0 cites·22 claims
- 2955US12344603B2Pyrido-pyrimidinone and pteridinone compounds and methods of useGENENTECH INC·Filed 2021·Granted Jul 1, 2025·0 cites·26 claims
- 3054US2015152117A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2015·Application pending·0 cites
- 3152US2019071404A1Therapeutic compounds, compositions and methods of use thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 3251US2018354959A1Therapeutic compounds, compositions and methods of use thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 3350US2016244456A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2016·Application pending·0 cites
- 3447US11279735B2Cyclic peptide antibioticsGENENTECH INC·Filed 2020·Granted Mar 22, 2022·0 cites·28 claims
- 3545US12071425B2Phenoxy-pyridyl-pyrimidine compounds and methods of useGENENTECH INC·Filed 2019·Granted Aug 27, 2024·0 cites·26 claims
- 3644US2022048888A1Pyrimidinyl-heteroaryloxy-naphthyl compounds and methods of useGENENTECH INC·Filed 2019·Application pending·0 cites
- 3743US10968203B2Pyrimidinyl-pyridyloxy-naphthyl compounds and methods of treating IRE1-related diseases and disordersGENENTECH INC·Filed 2018·Granted Apr 6, 2021·0 cites·41 claims
- 3841US10189836B2Therapeutic compounds, compositions and methods of use thereofGENENTECH INC·Filed 2018·Granted Jan 29, 2019·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Paul Gibbons files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →